000			01633 a2200445 4500
005			20250515191001.0
264		0	_c20100604
008			201006s 0 0 eng d
022			_a1029-2330
024	7		_a10.3109/10611860903318134 _2doi
040			_aNLM _beng _cNLM
100	1		_aAlcalá-Barraza, Sandra R
245	0	0	_aIntranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. _h[electronic resource]
260			_bJournal of drug targeting _cApr 2010
300			_a179-90 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Intranasal
650	0	4	_aAnimals
650	0	4	_aBlood-Brain Barrier _xmetabolism
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCentral Nervous System _xmetabolism
650	0	4	_aCentral Nervous System Diseases _xdrug therapy
650	0	4	_aDrug Delivery Systems
650	0	4	_aMale
650	0	4	_aNerve Growth Factors _xadministration & dosage
650	0	4	_aNeurons _xdrug effects
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Long-Evans
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aTime Factors
700	1		_aLee, Michael S
700	1		_aHanson, Leah R
700	1		_aMcDonald, Abby A
700	1		_aFrey, William H
700	1		_aMcLoon, Linda K
773	0		_tJournal of drug targeting _gvol. 18 _gno. 3 _gp. 179-90
856	4	0	_uhttps://doi.org/10.3109/10611860903318134 _zAvailable from publisher's website
999			_c19202314 _d19202314